Klaviyo Director & Officer Plans $3.6M Stock Sale Under 10b5-1 Plan
Klaviyo, Inc.
Subscribe to track KVYO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Klaviyo Director & Officer Plans $3.6M Stock Sale
Company: Klaviyo, Inc. (KVYO) Form: 144 | Filed: 2025-12-17 Significance: Low
Insider: Hallen Ed Relationship: Officer, Director
Transaction (Proposed): • Type: Sale • Shares: 117,550 • Value: ~$3,568,942 • Price/Share: ~$30.36
Key Insight: An insider has filed an intent to sell shares valued at approximately $3.6 million. The sale is part of a pre-arranged 10b5-1 trading plan, which reduces the likelihood of it being based on non-public information.
Market Context: The proposed sale represents a very small fraction (0.041%) of Klaviyo's $8.64 billion market cap, indicating a low market impact. This is likely a routine liquidity or diversification event for the insider.
Comprehensive Analysis
SEC Filing Analysis: Klaviyo, Inc. (KVYO)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A Director and Officer of Klaviyo has filed a notice of intent to sell 117,550 shares valued at approximately $3.6 million. The transaction is being conducted under a pre-established 10b5-1 trading plan.
- Market Impact: The proposed sale is minor relative to the company's market capitalization and public float, suggesting a negligible impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | Klaviyo, Inc. |
| Ticker Symbol | KVYO |
| CIK | 0001835830 |
| Industry | SERVICES-PREPACKAGED SOFTWARE [7372] |
Insider Information
| Field | Value |
|---|---|
| Name | Hallen Ed |
| CIK | 0001991125 |
| Title/Position | null |
| Relationship | Officer, Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-12-17 |
| Transaction Code | S (Proposed Sale) |
| Security Type | Series A |
| Shares Involved | 117,550 |
| Price Per Share | $30.36 |
| Total Value | $3,568,942.25 |
| Shares Owned After | null |
| Ownership Type | Indirect |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $3,568,942.25 |
| % of Market Cap | 0.041% |
| Shares Transacted | 117,550 |
| % of Shares Outstanding | 0.085% |
| Post-Transaction Ownership | Not Available |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market capitalization of $8.64 billion, this $3.6 million transaction is immaterial, representing just 0.041% of the company's value.
- Ownership Concentration: The sale constitutes only 0.085% of the 137.86 million shares outstanding, indicating no significant change in the company's ownership structure.
- Transaction Significance: The transaction size is well below the thresholds for moderate or high significance. It is a routine filing for an insider of a large-cap company.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is small in absolute and relative terms. Furthermore, its execution under a 10b5-1 trading plan adopted on June 12, 2025, signals that the decision to sell was made months in advance, delinking it from any immediate, private corporate developments.
Volume & Sentiment
- Expected Volume Impact: Minimal. The number of shares is unlikely to cause a noticeable impact on daily trading volume.
- Sentiment Indicator: Neutral. Pre-planned sales by long-term insiders are common for financial planning and do not typically signal a change in outlook on the company's future.
Additional Context
Transaction Notes
- Special Circumstances: This Form 144 filing represents a notice of proposed sale. The transaction is part of a 10b5-1 trading plan, which allows insiders to sell a predetermined number of shares at a predetermined time.
- Sale History: The filing notes several smaller sales by related entities (Hodgkins Trust, Hodgkins Llc) in the preceding three months, suggesting a consistent, planned liquidation schedule.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
